SAN DIEGO, October 26, 2023 – ResMed Inc. (NYSE: RMD, ASX: RMD) announced results for its
quarter ended September 30, 2023.
First Quarter 2024 Highlights
All comparisons are to the prior year period
• Revenue increased by 16% to $1.1 billion; up 15% on a constant currency basis
• Gross margin contracted 250 bps to 54.4%; non-GAAP gross margin contracted 160 bps to 56.0%
• Income from operations increased 5%; non-GAAP operating profit up 10%
• Operating cash flow of $286.3 million
• Diluted earnings per share of $1.49; non-GAAP diluted earnings per share of $1.64
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$40.98 |
Change
0.810(2.02%) |
Mkt cap ! $23.90B | |||
| Open | High | Low | Value | Volume |
| $40.80 | $41.07 | $40.71 | $9.935M | 243.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 667 | $40.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $40.99 | 9 | 1 |
View Market Depth
| Last trade - 12.47pm 23/07/2025 (20 minute delay) ? |
| RMD (ASX) Chart |